406 related articles for article (PubMed ID: 17386022)
1. Enhanced immunogenicity of modified hepatitis B virus core particle fused with multiepitopes of foot-and-mouth disease virus.
Zhang YL; Guo YJ; Wang KY; Lu K; Li K; Zhu Y; Sun SH
Scand J Immunol; 2007 Apr; 65(4):320-8. PubMed ID: 17386022
[TBL] [Abstract][Full Text] [Related]
2. DNA vaccines expressing B and T cell epitopes can protect mice from FMDV infection in the absence of specific humoral responses.
Borrego B; Fernandez-Pacheco P; Ganges L; Domenech N; Fernandez-Borges N; Sobrino F; Rodríguez F
Vaccine; 2006 May; 24(18):3889-99. PubMed ID: 16563575
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity of a recombinant fusion protein of tandem repeat epitopes of foot-and-mouth disease virus type Asia 1 for guinea pigs.
Zhang Q; Yang YQ; Zhang ZY; Li L; Yan WY; Jiang WJ; Xin AG; Lei CX; Zheng ZX
Acta Virol; 2002; 46(1):1-9. PubMed ID: 12199204
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of the epitope of the foot-and-mouth disease virus fused with a hepatitis B core protein as expressed in transgenic tobacco.
Huang Y; Liang W; Wang Y; Zhou Z; Pan A; Yang X; Huang C; Chen J; Zhang D
Viral Immunol; 2005; 18(4):668-77. PubMed ID: 16359233
[TBL] [Abstract][Full Text] [Related]
5. Enhanced immunogenicity of multiple-epitopes of foot-and-mouth disease virus fused with porcine interferon alpha in mice and protective efficacy in guinea pigs and swine.
Du Y; Li Y; He H; Qi J; Jiang W; Wang X; Tang B; Cao J; Wang X; Jiang P
J Virol Methods; 2008 Apr; 149(1):144-52. PubMed ID: 18294705
[TBL] [Abstract][Full Text] [Related]
6. Generation of chimeric HBc proteins with epitopes in E.coli: formation of virus-like particles and a potent inducer of antigen-specific cytotoxic immune response and anti-tumor effect in vivo.
Zhang Y; Song S; Liu C; Wang Y; Xian X; He Y; Wang J; Liu F; Sun S
Cell Immunol; 2007 May; 247(1):18-27. PubMed ID: 17707782
[TBL] [Abstract][Full Text] [Related]
7. Expressions of Bovine IFN-gamma and foot-and-mouth disease VP1 antigen in P. pastoris and their effects on mouse immune response to FMD antigens.
Shi XJ; Wang B; Zhang C; Wang M
Vaccine; 2006 Jan; 24(1):82-9. PubMed ID: 16135391
[TBL] [Abstract][Full Text] [Related]
8. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. presentation of foreign epitopes.
Schödel F; Peterson D; Hughes J; Wirtz R; Milich D
J Biotechnol; 1996 Jan; 44(1-3):91-6. PubMed ID: 8717391
[TBL] [Abstract][Full Text] [Related]
9. Comparison of immune responses against foot-and-mouth disease virus induced by fusion proteins using the swine IgG heavy chain constant region or beta-galactosidase as a carrier of immunogenic epitopes.
Li G; Chen W; Yan W; Zhao K; Liu M; Zhang J; Fei L; Xu Q; Sheng Z; Lu Y; Zheng Z
Virology; 2004 Oct; 328(2):274-81. PubMed ID: 15464847
[TBL] [Abstract][Full Text] [Related]
10. Orally delivered foot-and-mouth disease virus capsid protomer vaccine displayed on T4 bacteriophage surface: 100% protection from potency challenge in mice.
Ren ZJ; Tian CJ; Zhu QS; Zhao MY; Xin AG; Nie WX; Ling SR; Zhu MW; Wu JY; Lan HY; Cao YC; Bi YZ
Vaccine; 2008 Mar; 26(11):1471-81. PubMed ID: 18289743
[TBL] [Abstract][Full Text] [Related]
11. Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein.
Clarke BE; Newton SE; Carroll AR; Francis MJ; Appleyard G; Syred AD; Highfield PE; Rowlands DJ; Brown F
Nature; 1987 Nov 26-Dec 2; 330(6146):381-4. PubMed ID: 2446137
[TBL] [Abstract][Full Text] [Related]
12. Screen of multifunctional monoclonal antibodies against hepatitis B core virus-like particles.
Sun C; Ding FX; Wang F; He XW; He Y; Li ZS; Sun SH
Microbiol Immunol; 2009 Jun; 53(6):340-8. PubMed ID: 19493202
[TBL] [Abstract][Full Text] [Related]
13. Vesicular Stomatitis Virus glycoprotein G carrying a tandem dimer of Foot and Mouth Disease Virus antigenic site A can be used as DNA and peptide vaccine for cattle.
Capozzo AV; Wilda M; Bucafusco D; de los Ángeles Lavoria M; Franco-Mahecha OL; Mansilla FC; Pérez-Filgueira DM; Grigera PR
Antiviral Res; 2011 Nov; 92(2):219-27. PubMed ID: 21889542
[TBL] [Abstract][Full Text] [Related]
14. [Molecular design and immunogenicity of a multiple-epitope foot-and-mouth disease virus antigen, adjuvants, and DNA vaccination].
Ma M; Jin N; Yin G; Lu H; Li C; Jin K; Qu Z
Sheng Wu Gong Cheng Xue Bao; 2009 Apr; 25(4):514-9. PubMed ID: 19637624
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus core-preS2 particles expressed by recombinant vaccinia virus.
Nemecková S; Sroller V; Kunke D; Krystofová J; Kutinová L
Acta Virol; 1996; 40(5-6):273-9. PubMed ID: 9171455
[TBL] [Abstract][Full Text] [Related]
16. A novel bi-functional DNA vaccine expressing VP1 protein and producing antisense RNA targeted to 5'UTR of foot-and-mouth disease virus can induce both rapid inhibitory effect and specific immune response in mice.
Yang B; Lan X; Li X; Yin X; Li B; Han X; Li Y; Zhang Z; Liu J
Vaccine; 2008 Oct; 26(43):5477-83. PubMed ID: 18694793
[TBL] [Abstract][Full Text] [Related]
17. [Fusion expression of O type foot-and-mouth diseases virus VP1 gene and HSP70 gene and induction of immune responses in mice].
Su CX; Duan XG; Wang XQ; Ren XF; Cao RB; Zhou B; Chen PY
Sheng Wu Gong Cheng Xue Bao; 2006 Sep; 22(5):733-6. PubMed ID: 17037194
[TBL] [Abstract][Full Text] [Related]
18. DNA vaccination against foot-and-mouth disease via electroporation: study of molecular approaches for enhancing VP1 antigenicity.
Kim SA; Liang CM; Cheng IC; Cheng YC; Chiao MT; Tseng CJ; Lee F; Jong MH; Tao MH; Yang NS; Liang SM
J Gene Med; 2006 Sep; 8(9):1182-91. PubMed ID: 16927362
[TBL] [Abstract][Full Text] [Related]
19. Recombinant virus-like particles as a carrier of B- and T-cell epitopes of hepatitis C virus (HCV).
Mihailova M; Boos M; Petrovskis I; Ose V; Skrastina D; Fiedler M; Sominskaya I; Ross S; Pumpens P; Roggendorf M; Viazov S
Vaccine; 2006 May; 24(20):4369-77. PubMed ID: 16574285
[TBL] [Abstract][Full Text] [Related]
20. A novel virus-like particle based on hepatitis B core antigen and substrate-binding domain of bacterial molecular chaperone DnaK.
Wang XJ; Gu K; Xiong QY; Shen L; Cao RY; Li MH; Li TM; Wu J; Liu JJ
Vaccine; 2009 Dec; 27(52):7377-84. PubMed ID: 19778518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
